Right now the price per share is 7,43$, Larimar Therapeutics Inc, with address at THREE BALA PLAZA EAST SUITE 506, BALA CYNWYD, Pennsylvania, 19004, United States, is a publicly traded company and its visible heads at the moment are Carole S. Ben-Maimon (President, Chief Executive Officer & Director), David Bettoun (Vice President-Discovery & Non-Clinical R&D), John Berman (Treasurer, Vice President-Finance & Operations), Michael Celano (Chief Financial Officer), Noreen Scherer (Vice President-Clinical Operations). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 7,34$ - 8,11$, with a percentage difference of 7,73$ quite wide that helps to be able to do day trading.
The company has an annual revenue of desconocido.
The last value we have registered for the opening is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
